Eeyarestatin 1 (ES1) inhibits p97-dependent protein degradation, Sec61-dependent protein translocation into the endoplasmic reticulum (ER), and vesicular transport within the endomembrane system. Here, we show that ES1 impairs Ca 2+ homeostasis by enhancing the Ca 2+ leakage from mammalian ER. A comparison of various ES1 analogs suggested that the 5-nitrofuran (5-NF) ring of ES1 is crucial for this effect. Accordingly, the analog ES24, which conserves the 5-NF domain of ES1, selectively inhibited protein translocation into the ER, displayed the highest potency on ER Ca 2+ leakage of ES1 analogs studied and induced Ca 2+
INTRODUCTION
The endoplasmic reticulum (ER) is the intracellular organelle in which most secretory and many transmembrane proteins are folded and assembled in eukaryotic cells (Cross et al., 2009b; Lang et al., 2017; Rapoport et al., 2017) . Early studies revealed that this organelle also stores Ca 2+ in an ATP-dependent manner (Carreras-Sureda et al., 2018) . It is now widely accepted that the ER represents the major intracellular Ca 2+ reservoir and, thus, it is essential for both protein biogenesis and intracellular Ca 2+ signaling in the mammalian cell. Generally, the total Ca 2+ stored in ER are in the order of 1-3 mM and the luminal free Ca 2+ concentration in ER ([Ca 2+ ] ER ) can reach 100-800 mM, which represents more than 1,000-fold of the cytosolic Ca 2+ concentration ([Ca 2+ ] cyt ) at rest (Carreras-Sureda et al., 2018) . However, the ER membrane is significantly more leaky than other cell membranes (Le Gall et al., 2004) . Hence Ca
2+
, among other cations, permeates the ER membrane and gives rise to Ca 2+ leakage from ER as a result of the steep ER-cytosol Ca 2+ gradient . Since ER Ca 2+ leakage can be unmasked by inhibiting sarco/ER Ca 2+ ATPases (SERCA) in multiple cell types, it is generally assumed that [Ca 2+ ] ER is maintained by balancing ER Ca 2+ leakage and ATP-dependent Ca 2+ influx into the ER via SERCA pumps Carreras-Sureda et al., 2018) . The molecular structure of Ca 2+ leak channels in the ER has not yet been fully elucidated , but it is remarkable that the ubiquitously expressed Sec61 complex has been identified as a high-conductance Ca 2+ -permeable channel that can support Ca 2+ leakage from the ER (Simon and Blobel, 1991; Lomax et al., 2002; Wirth et al., 2003; Van Coppenolle et al., 2004; Erdmann et al., 2011) . The core of the Sec61 complex consists of Sec61a, Sec61b, and Sec61g, where Sec61a forms a protein-conducting channel that facilitates the translocation of secretory and transmembrane proteins into the ER (Lang et al., 2017) . Apparently, Sec61 complexes become Ca 2+ permeable only after protein translocation and the resulting Sec61-mediated Ca 2+ leakage is limited by cytosolic Ca 2+ -calmodulin and the ER luminal chaperone immunoglobulin heavy-chain binding protein under physiological conditions (Erdmann et al., 2011; Sch€ auble et al., 2012) . Given the ubiquitous expression of Sec61 complexes in eukaryotic cells, Sec61-mediated Ca 2+ leakage is emerging as an important pharmacological target within the field of Ca 2+ homeostasis. However, little is known about small molecules that modulate ER Ca 2+ leakage by targeting Sec61 complexes. For instance, puromycin enhances the Sec61-mediated Ca 2+ leakage Van Coppenolle et al., 2004; Lang et al., 2011a) , but, mechanistically, puromycin is a substrate for the ribosomal peptidyltransferase and clears nascent polypeptide chains from protein-conducting channels in the ER membrane (Simon and Blobel, 1991) . Some inhibitors of protein translocation across the ER membrane bind directly to the Sec61 complex and stabilize it in a closed state (van Puyenbroeck and Vermeire, 2018) . With the exception of exotoxin A (Sch€ auble et al., 2014) , however, it is not known whether Sec61 complexes that have been blocked by translocation inhibitors become permeable or are sealed for Ca 2+ fluxes.
Eeyarestatin 1 and eeyarestatin 2 (ES1 and ES2) are small molecules that were initially identified as inhibitors of protein dislocation from ER into the cytosol (Fiebiger et al., 2004) . Subsequent studies have shown that ES1 is an inhibitor of ER-associated protein degradation (ERAD), which targets the cytosolic AAA-ATPase p97, leading to the accumulation of poly-ubiquitinated ERAD substrates (Wang et al., 2008 (Wang et al., , 2010 . Supporting this idea, it has been shown that ES1 is particularly cytotoxic against cancer cells when combined with proteasome inhibitors (Wang et al., 2009; Auner et al., 2013) . Additional mechanisms that potentially contribute to the cytotoxic effects of ES1 are the impairment of both intracellular vesicular transport and membrane insertion of tail-anchored proteins (Aletrari et al., 2011; Naydenov et al., 2012; Figueiredo Costa et al., 2018) . Independently of targeting the ER-cytosol dislocation of proteins, ES1 also inhibits the co-translational translocation of nascent polypeptides into the ER, most likely by inhibiting Sec61 complexes both in cellula and in vitro (Cross et al., 2009a) . The ES1-dependent inhibition of protein translocation at the ER leads to an almost complete loss of glycoprotein secretion (Cross et al., 2009a) and, after $2 h of exposure to ES1, cells also begin to show signs of ER stress in the form of the unfolded protein response (McKibbin et al., 2012) . Thus, ES1 apparently affects ER functions at various levels, including co-translational protein translocation through Sec61 complexes (Cross et al., 2009a) and, since Sec61 complexes support Ca 2+ fluxes through ER membranes (Lang et al., 2017) , it can be predicted that ES1 treatment of cells will also impact on ER Ca 2+ homeostasis. However, whether the ES1-mediated blockade of co-translational translocation is accompanied by the opening or closing of Sec61 complexes to Ca 2+ ions is unknown. However, all cells treated with 0.1 and 1 mM ES1 successfully removed the large amounts of Ca 2+ that were released by TG into the cytosol ( Figure 1A ). Based on these observations, we suggest that ES1 does not disturb the clearance of Ca 2+ from the cytosol, at least during the 17-min exposure to the compound. In addition, the fact that TG was largely ineffective after treatment with 10 mM ES1 ( Figure 1A ) underpinned the suggestion that ES1 primarily mobilizes Ca 2+ from TG-sensitive Ca
stores. This suggestion is further supported by the analysis of [Ca 2+ ] ER that was measured simultaneously in the same set of cells ( Figure 1B ). The loss of ER Ca 2+ due to EGTA in the bath solution was relatively low before TG application ($0.75% per min). By contrast, [Ca 2+ ] ER began to decrease immediately after application of 1-10 mM ES1 ( Figure 1B) . Thus, the [Ca 2+ ] ER imaging experiments strongly suggest that ES1 specifically impaired ER Ca 2+ homeostasis in a dose-dependent manner.
The possible involvement of IP 3 receptors in the effects of ES1 is unlikely because the decrease of [Ca 2+ ] ER was also observed in the presence of IP 3 inhibitors ( Figure S1 ). One possible explanation for this effect is that ES1 might have inhibited SERCA pumps. A second, not necessarily exclusive, explanation is that ES1 might have enhanced Ca 2+ leakage from the ER. We therefore inhibited SERCA pumps with TG in order to determine the specific effects of ES1 on Ca 2+ leakage and found that ES1 apparently enhanced the Ca 2+ leakage rate such that the TG-induced decay of [Ca 2+ ] ER became faster as the ES1 concentration was increased from 0.1 to 1 mM, suggesting that ES1 induced a dose-dependent gain of Ca 2+ leakage ( Figure 1B ). ] ER levels, the cytosolic responses to TG were higher in cells treated with 10 mM ES1 for 4 min than in those treated with 1 mM ES1 (Figure 1C) . In 4-min treatments, however, the [Ca 2+ ] ER levels decayed to lower levels in cells exposed to 10 mM ES1 than in those treated with 1 mM ES1 ( Figure 1D ). The most likely explanation for these apparently contradictory results is that 10 mM ES1 enhanced the Ca 2+ leakage sufficiently strongly to compen- ] ER levels were significantly lower after a 17-min exposure than after a 4-min exposure to 1 mM ES1 ( Figures 1B and 1D) . Surprisingly, however, the cytosolic responses to TG were similar after 4-and 17-min treatments with 1 mM ES1 ( Figures  1A and 1C Figures 1E-1G ). Specifically, post-TG t 1/2 showed the dose-dependent gain of Ca 2+ leakage induced by ES1 (Figure 1G) . Based on the analysis of post-TG AUC, pre-TG [Ca 2+ ] ER and post-TG t 1/2 , it can be estimated that the half maximal effective concentration (EC 50 ) for the effects of ES1 on cytosolic and ER Ca 2+ is approximately 1 mM ( Figures   1E-1G ). The low post-TG AUC values in the presence of 1 mM ES1 ( Figure 1E ) reflected mainly the shortening of the whole TG response ( Figure 1A ), which in turn paralleled the decrease of [Ca 2+ ] ER ( Figure 1F ) and the increase of the Ca 2+ leak constant, seen as a shortening of post-TG t 1/2 ( Figure 1G) ES1 comprises two structural and functional distinct domains ( Figure 2A ): a 5-NF-containing domain and an aromatic domain (Wang et al., 2010; Aletrari et al., 2011; McKibbin et al., 2012) .
In our present study, we have used the closely related analog ES2 and compounds ES24, ESR35, and ES47 ( TG application (pre-TG t 1/2 ) was approximately two times shorter for ES24 than for ES1 at 10 mM ( Figure 2G ). Therefore, the ER was completely empty at the end of the 17-min treatment with ES24 and cytosolic TG responses were absent ( Figure 2F ), meaning that we were not able to estimate the actual increase in Ca 2+ leakage induced by ES24, i.e., post-TG t 1/2 ( Figure 2H ).
As an alternative, we applied TG and ES24 simultaneously and found that this combination results in a 5-fold reduction in post-TG t 1/2 , suggesting that ES24 is a potent enhancer of Ca 2+ leakage ( Figure S2 ). We also observed a continuous increase of [Ca 2+ ] cyt after 10-12 min exposure to ES24, pointing toward the risk of non-selective, cytotoxic effects of ES24 at prolonged exposures ( Figure 2B ). By contrast to ES24, the effects of ES2 on both [Ca 2+ ] cyt and [Ca 2+ ] ER were less pronounced than those of ES1 ( Figures 2B and 2C ). The pre-TG t 1/2 for the decay of [Ca 2+ ] ER induced by ES2 was about twice as long as in the presence of ES1 ( Figure 2G ). Accordingly, the loss of ER Ca 2+ and the Ca 2+ accumulation in cytosol were less pronounced under the treatment with ES2 ( Figure 2C ) and cytosolic TG responses were detectable ( Figure 2F ). In contrast, ESR35, which has previously been used as an inactive control ] ER (Figures 2D and 2E) . ES47, however, displayed a small but statistically significant inhibition of Ca 2+ leakage from ER ( Figure 2I ) that was paralleled by an increase in the post-TG half-time by circa 16% ( Figure 2J ).
The 5-NF Domain of ES1 Enhances Ca 2+ Fluxes through Sec61 Complexes To examine the mechanism through which ES1 enhances Ca 2+ leak, cells were depleted of Sec61a using small interfering RNA (siRNA). We performed these experiments in HeLa cells, in which silencing efficiencies of about 80% are routinely achieved (Lang et al., 2011b) . Two independent siRNAs, SEC61A1#4 and SEC61A1#5, were used to silence SEC61A1, and a scrambled siRNA (scr siRNA) was used as a control. Following our online protocol, HeLa cells were exposed to 10 mM ES1 and ES24, and the amplitude of cytosolic TG responses (post-TG D[Ca 2+ ] cyt ) was measured as an indicator for Ca 2+ leakage (Figures 3A and 3B) . In cells treated with either of two independent siRNAs, SEC61A1#4 and SEC61A1#5A, we consistently observed lower peaks in the cytosolic responses to TG (Figures 3A and 3B) , and the post-TG D[Ca 2+ ] cyt was about 35%-40% lower than in scr siRNA-treated cells ( Figures 3C and 3D ). Similar effects of SEC61A1 silencing on cytosolic TG responses have been observed previously and were attributed to a decrease in Sec61-mediated Ca 2+ leakage from ER (Erdmann et al., 2011) . Western blot analysis confirmed that the two siRNAs reduced the Sec61a subunit by circa 80%-82% in HeLa cells ( Figures 3E and 3F ). The cytosolic TG responses of scr siRNA-treated HeLa cells exposed to ES1 and ES24 peaked higher and were of shorter duration than mock treated cells ( Figures 3A and 3B in scr siRNA-treated cells but it was completely ineffective after silencing SEC61A1 (Figures 3 B and 3D) . A potential explanation for this finding is that ES1 and ES24 were not effective after silencing SEC61A1 because of low post-TG D[Ca 2+ ] cyt levels. As an additional control, we have therefore reduced the amplitude of cytosolic TG responses via an independent mechanism, namely by reducing SERCA protein levels to about 60% using siRNA SERCA2. Under these conditions, the levels of post-TG D [Ca 2+ ] cyt were as low as those measured after silencing SEC61A1 and, remarkably, we found that 10 mM ES1 and 1 mM ES24 enhanced the cytosolic TG responses ( Figure S3 ). Thus, these results strongly suggest that the mechanism by which ES1 and ES24 disrupt cellular Ca 2+ homeostasis is via a specific enhancement of Sec61-mediated Ca 2+ leakage. Hence, we conclude that ER resident Sec61 complexes are targets for both ES1 and ES24.
Differential Effects of ES Compounds on Protein
Degradation and ER Translocation ES1 interacts with the p97 complex and influences deubiquitinating processes that are mediated by p97-associated enzymes thereby inhibiting downstream proteasomal degradation and protein quality control (Wang et al., 2008) . One of the hallmarks of this effect is an accumulation of high-molecular-weight polyubiquitinated species in cells exposed to ES1 for several hours (Wang et al., 2008; McKibbin et al., 2012) , and we used this as a readout to compare the effects of our ES compounds on cellular ubiquitin homeostasis and related protein quality control processes. As described previously (Wang et al., 2008; McKibbin et al., 2012) , the treatment of HeLa cells with 8 mM ES1 induced a $3.4-fold increase of total poly-ubiquitinated species when compared with control cells (Figures 4A and 4B ).
Likewise, a substantial, accumulation of poly-ubiquitinated species was also observed in cells treated with ES2 ( Figures  4A and 4B ). In contrast, the effects of ES24 were by far less robust and, although a modest qualitative increase in signal was sometimes apparent ( Figure 4A , cf. lanes 1 and 4), quantification showed that any changes were not statistically significant when compared with cells treated either with DMSO or ESR35 ( Figure 4B ). We speculate that the absence of any clear perturbation of ubiquitin homeostasis following treatment with ES24 reflects its lack of the distinct aromatic domain present in ES1 (cf. Figure 2A ). This region is proposed to enhance the inhibitory effects of ES1 on the degradation of misfolded membrane proteins by targeting the compound to the ER where it may preferentially inhibit membrane-bound p97 (Wang et al., 2010) . ES47 was also ineffective at causing any accumulation of poly-ubiquitinated species ( Figure 4B ) and, since it lacks an intact 5-NF domain (cf. Figure 2A ), our findings support the proposal that this region is important for ES1-mediated inhibition of p97 (Wang et al., 2010) . In summary, of the ES compounds that we analyzed, only ES1 and ES2 appear to cause the accumulation of endogenous poly-ubiquitinated species in HeLa cells, most likely via their inhibition of protein degradation (Fiebiger et al., 2004; Wang et al., 2010; McKibbin et al., 2012) .
Since it has been shown that ES1 and ES2 inhibit Sec61-mediated protein translocation into the ER (Cross et al., 2009a) , we studied the effects of our ES compounds using an -established cell-free membrane translocation assay. The histocompatibility leukocyte antigen (HLA) class II histocompatibility antigen gamma chain (Ii) was used as a model membrane glycoprotein, and its integration into ER-derived canine . Ubiquitin signals were normalized relative to b-actin loading controls and normalized ubiquitin intensities are expressed relative to DMSO controls (B). The total levels of poly-ubiquitinated proteins were markedly increased in cells treated with ES1 and ES2 but not with ESR35 and ES47, while the effects of ES24 were not statistically significant compared with DMSO controls. (C and D) ES1, ES2, and ES24 reduced in vitro the glycosylation of a model membrane glycoprotein, the invariant chain (Ii) of the class II major histocompatibility complex, while ESR35 and ES47 had no inhibitory effect. Fully glycosylated Ii is denoted by li-2 Gly (C). Pancreatic ER ribosomes were preincubated for 1 h with ES1 analogs (250 mM) or with equal amounts of DMSO. Ratios of signal intensities li-2 Gly/Ii were used as a measure for total protein translocation and expressed relative to DMSO controls to estimate the relative ER processing (D). Quantifications are given as means ± SEM for three translocation experiments and six ubiquitination assays. n.s., not significant; *p < 0.05; **p < 0.01. pancreatic microsomes that had been pre-incubated with the different ES compounds was investigated as described previously (Cross et al., 2009a) . Hence, the efficiency of the Sec61-mediated translocation of the N-terminal domain of Ii into the ER lumen was determined by quantifying its N-glycosylation. As reported previously, ES1 and ES2 inhibited membrane translocation by $90% (Figures 4C and 4D ), while ESR35 had no effect (Cross et al., 2009a) . Strikingly, the effects of ES24 and ES47 on protein translocation mirrored their effects on Sec61-dependent Ca 2+ leakage (Figure 2 ), and hence ES24 inhibited the Nglycosylation of Ii to a similar extent as ES1 and ES2, while ES47 had no effect ( Figures 4C and 4D) .
In summary, ES1 and ES2 efficiently inhibited both protein poly-ubiquitination in cellula and ER protein translocation in vitro, while ESR35 and ES47 showed no effect on either the ubiquitination or translocation assays (Figure 4 ). This suggests that ES1 and ES2 have at least two cellular targets within the protein homeostatic network. Firstly, the inhibition of protein translocation into the ER by ES1 and ES2 is most likely due to a direct effect on the Sec61 complex (Cross et al., 2009a) . Secondly, ES1 and ES2 may influence de-ubiquitinating processes by interacting directly with p97 (Wang et al., 2008; McKibbin et al., 2012) . This dichotomy between Sec61-and p97-mediated effects is apparently absent in the cellular action of ES24, which efficiently inhibits ER translocation but has little if any effect on protein deubiquitination (Figure 4) . Thus, our results suggest that ES24 Color and symbol coding for cell lines and substances are shown below panels. Cell viability was measured per duplicate in three independent experiments, normalized to DMSO controls and is presented as means ± SD.
selectively inhibits protein translocation at the ER, most likely by interacting with Sec61 complexes. This view is strongly supported by the enhancement of Sec61-dependent Ca 2+ leakage that is observed when cells are treated with either ES1 or ES24.
Differential Effects of ES Compounds on Cell Death
ES1 has been shown to induce cell death in human blood cancer cell lines, and the 5-NF domain of ES1 was apparently pivotal to this cytotoxic effects (Wang et al., 2010; Auner et al., 2013) . To evaluate the role of ER Ca 2+ leakage in the cytotoxicity of ES compounds, we next compared the sensitivities of various cell lines with ES1, ES24, and ESR35 ( Figure 5) . HEK, HeLa, INS-1, and NALM-6 cells were first exposed to these compounds for 24 h at concentrations ranging between 0.1 and 20 mM, and cell viability was then evaluated using the Guava ViaCount assay. As shown in Figure 5A , ES1 was toxic to all cell lines tested. As predicted from the lack of effect of ESR35 on Ca 2+ flux and protein processing (Figures 2 and 4) , ESR35 was not toxic to the cell lines tested in the present study ( Figure 5A ). ES24 exhibited a surprisingly mild cytotoxicity on INS-1 and NALM-6 cells, and had no effect on the viability of HEK and HeLa cells at concentrations up to 20 mM ( Figure 5A ). Based on the well-defined effects of ES24 on Ca 2+ leakage and protein translocation (Figures 2 and  4) we hypothesized that, in contrast to the more complex effects of ES1 (Wang et al., 2010) , the cytotoxicity of ES24 may primarily reflect its effects on Sec61 complexes. To correlate the toxic effects of ES1 and ES24 with an enhancement of ER Ca 2+ leakage, we determined the cell tolerance to the disruption of Ca 2+ homeostasis by treatment with TG for 24 h. As with ES24, we found that HEK and HeLa cells were insensitive to TG (cell viability: HEK, 117.90% ± 3.32%; HeLa, 106.28% ± 2.90%), while INS-1 and NALM-6 cells were more prone to the effects of disruption of the Ca 2+ homeostasis by TG (cell viability: INS-1, 81.46% ± 5.18%; NALM-6, 75.06% ± 5.20%). Combining the cell viability data for ES24 and TG, we observed a striking correlation between cell viabilities in the presence of ES24 and TG (Figure 5B ), indicating that cell lines with high sensitivity to TG are also more sensitive to ES24. The effects of ES1 and ESR35 on cell viability were not correlated with the cell viabilities under TG treatment (not shown). Although our cytotoxicity studies did not address any potential contribution of the inhibition of protein translocation at ER, our data highlight the role of Sec61-mediated Ca 2+ leakage in the cytotoxic effects of ES24
( Figure 5 ). Since TG prevents Ca 2+ influx into the ER by inhibiting SERCA pumps, the TG effect can be seen as the counterpart of an enhancement of Ca 2+ leakage. Therefore, the linear relationship between the cytotoxic effects of ES24 and TG shown in Figure 5B suggests that the actions of TG and ES24 may mechanistically converge on ER Ca 2+ depletion. Conversely, the cytotoxic effects of ES1 may be dominated by p97 inhibition. dependent. ES1 has been show to inhibit protein degradation at the level of p97, an effect that requires the 5-NF domain (Wang et al., 2010) . In this study, we observed an accumulation of poly-ubiquitinated species consistent with such an inhibition of protein degradation by ES1 (Figure 4) . It is unclear whether these effects of ES1 on protein degradation disturb Ca 2+ homeostasis in the ER, but,
DISCUSSION
given that ES24 has a strong effect on Ca 2+ leakage without a comparable effect on ubiquitin homeostasis, these processes may be distinct. Nevertheless, it is conceivable that the cellular accumulation of poly-ubiquitinated proteins over a period of hours may affect Ca 2+ leakage. For instance, an increase in cytosolic Ca 2+ levels is detected hours after exposure to proteasome inhibitors (Williams et al., 2013) . Notably, in the present study, we found that that ES1 enhanced ER Ca 2+ leakage in a timescale of seconds to minutes (Figures 1, 2, and 3) . Furthermore, silencing of SEC61A1 abolished the ES1 effects on ER Ca 2+ leakage completely (Figure 3 ), indicating that Sec61 complexes are central targets for the action of ES1 at the ER. Like ES1, ES2 and ES24 both enhance ER Ca 2+ leakage (Figure 2 ) and inhibit protein translocation (Figures 4C and 4D ; see also Cross et al., 2009a) , and we assume that these effects also reflect the interaction of ES2 and ES24 with Sec61 complexes. Compared with ES1 and ES2, however, ES24 showed the strongest effects on ER Ca 2+ leakage generating a robust response within seconds ( Figure 2 ). Effects on Sec61-mediated Ca 2+ leakage with a similar timescale have been described for inducers of ER stress and protein synthesis inhibitors Van Coppenolle et al., 2004; Lang et al., 2011a; Sch€ auble et al., 2012) . Remarkably, a 10-min exposure to ES1 is also sufficient to observe a reduction in Sec61-mediated protein translocation, suggesting the ES1-mediated inhibition of this process is also a rapid event (Cross et al., 2009a) .
The dual effects on Sec61 complexes of ES1, ES2, and ES24 (Figures 3 and 4) indicate that active ES compounds prevent protein translocation into the ER while maintaining Sec61 complexes in a Ca 2+ -permeable state. Thus, the question arises as to how these apparently opposite effects on protein translocation and Ca 2+ leakage can be reconciled in a mechanistic model for the action of ES compounds on Sec61 complexes. Using the crystal structure of canine Sec61a (Voorhees and Hegde, 2016), we modeled the structure of Sec61a in the open state ( Figure 6A ). According to the current view, Sec61a is formed by ten transmembrane helices arranged in two halves (Rapoport et al., 2017) . In the idle state, Sec61a is closed by the pore ring and the plug structure. After priming by the ribosome binding, the transmembrane helices rotate in a way that the lateral gate formed by transmembrane helices 2 and 7 is opened and the aqueous channel within Sec61a becomes free for protein translocation (Voorhees and Hegde, 2016) . Docking analysis with the Sec61a structure revealed that ES1 interacts with Sec61a with a high affinity (DG = À9.62 kcal/mol). Specifically, the 5-NF group of ES1 interacts with H7 and H8 and occupies the volume between H2 and H7 ( Figure 6B ). Our model predicts that ES24 also binds with a high affinity (DG = À9.04 kcal/mol) and interacts with the N-terminal region of H7 ( Figure 6C) . Remarkably, the aromatic ring of ES24 and the 5-NF group of ES1 docked at the same place surrounded by H2, H7, and H8 at the cytosolic end of the lateral gate. Docking the 5-NF domain alone revealed that it also binds preferentially at the cytosolic end of the lateral gate ( Figure S4 ). This putative interaction site differs from the presumptive binding sites of other Sec61 inhibitors that have been proposed to stabilize the plug domain in a closed state and to prevent allosterically the opening of Sec61 complexes (van Puyenbroeck and Vermeire, 2018). We have estimated the distance of these presumptive binding sites to the lateral gate and found that, with the exception of T86M, they are quite distant and, therefore, unlikely to affect the binding of ES compounds ( Figure S5A ). Docking analysis with a structural model of the T86M mutant predicted that T86M has only minor effects on the docking of ES1 and ES24 ( Figure S5B ). The interactions of ES1 and ES24 with Sec61a are predicted to adopt rather central positions at short distances to the center of the H2-H7 gap (9.98 and 9.87 Å for ES1 and ES24, respectively). By contrast, the closest distance between ESR35 and the H2-H7 gap was calculated to be 15.06 Å , and the estimated affinity of its interaction with ESR35 is lower (DG = À7.91 kcal/mol). We do not know whether the interaction of ES1 and ES24 with Sec61a is reversible, but a parsimonious model suggests that these ES compounds interact with the helices forming the lateral gate and hamper conformational changes of Sec61a. This is equivalent to proposing that ES1 and ES24 promote an open, Ca 2+ -permeable, state of Sec61a by preventing the closing of the lateral gate ( Figure 6D ). Compared with other ion channels, this mechanism Yeh and Armstrong, 1978) . In general, however, the consequence of such a foot in the door effect is that ion movements through the pore are blocked. Our model implies that ES compounds keep the lateral gate open as a foot in the door allowing Ca 2+ ions to move freely through the aqueous channel present in Sec61a after protein translocation ( Figure 6D ). ES1 has been proposed as an anticancer agent (van Puyenbroeck and Vermeire, 2018) and, accordingly, aqueous soluble derivatives of ES1 have been developed for cancer therapy (Ding et al., 2016) . As shown previously with multiple myeloma cell lines (Auner et al., 2013) , we found that the cytotoxicity of ES1 varied between cell lines. ES1 and ES24 not only enhanced the Sec61-mediated Ca 2+ leakage from ER (Figures 2 and 3 ), but also inhibited protein translocation (Figure 4 ). Our model predicts that these ES compounds enhance the Ca 2+ leakage in the short term and, in the long term, deplete the pool of translocationcompetent Sec61 complexes and thereby restrict the process of co-translational protein translocation (Figure 6 ). We found that the gain of Ca 2+ leakage induced by ES24 was the predominant mechanism in the cytotoxicity of the compound and that the degree of toxicity depends on cell type ( Figure 5 ). Thus, our study identified ES24 as a small molecule that targets Sec61 complexes and causes cell-type-specific Ca
2+
-dependent cell death.
SIGNIFICANCE
Small molecules that target Sec61 complexes have been described as antimicrobial and anticancer agents (van Puyenbroeck and Vermeire, 2018) . While inhibition of protein translocation by these compounds has been a focus of research, their effects on the ion channel properties of Sec61 complexes are poorly understood. Sec61 complexes can support Ca 2+ leakage from ER (Lang et al., 2017) -permeable, open state. This unprecedented mechanism of action best resembles a ''foot in the door'' effect, in which ion channel closing is prevented without interference of the ion-conducting pathway. We have tested selected ES1 analogs and found that ES24, in which the chemical structure is basically reduced to the 5-NF domain of ES1, has higher selectivity toward Sec61 complexes than the parental ES1. Hence, among the ES1 analogs tested, ES24 showed the strongest effects on Sec61-mediated Ca 2+ leakage and, consequently, the cytotoxic effects of ES24 were Ca 2+ dependent. Thus, our work illustrates a strategy with therapeutic potential, namely one which targets cellular Ca 2+ homeostasis by taking advantage of the ion channel properties of Sec61 complexes.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
HEK cells (human epithelial embryonic kidney cells, ATCC) were cultivated in Dulbecco's Modified Eagle's Medium (DMEM) supplemented with 10% (v/v) foetal bovine serum (FBS). In order to obtain cells with homogenous expression levels of the FRET-based Ca 2+ -sensor D1ER, we generated the stable cell line HEK D1ER by transfecting HEK cells with the plasmid pcDNA3-D1ER (Palmer et al., 2004) , which was kindly provided R. Y. Tsien (University of California San Diego, La Jolla, USA). HEK-D1ER cells were maintained in culture under selection with G418 (0.5 mg/ml) in Minimal Essential Medium (MEM) supplemented with 10% (v/v) FBS. HeLa cells (human epithelial cervix carcinoma cells, ATCC, female) were cultured in DMEM supplemented with 10% (v/v) FBS and 2 mM L-alanyl-L-glutamine. NALM-6 (human B-cell precursor leukaemia cells, DSMZ, male) were cultured in RPMI 1640 medium supplemented with 10% (v/v) heat-inactivated FBS. INS-1 cells are derived from rat insulinoma (Asfari et al., 1992) and were kindly provided by P. O. Berggren (Karolinska Institute, Stockholm, Sweden). The culture medium of INS-1 cells was RPMI 1640 supplemented with 10% (v/v) heat-inactivated FBS, 50 mM b-mercaptoethanol and 1 mM Na-pyruvate. All cell lines were maintained in a 5% CO 2 humidified incubator at 37 C.
METHOD DETAILS

Synthesis of Eeyarestatin (ES) Compounds
The compounds ES1, ES2 and ESR35 were synthesized as previously described (McKibbin et al., 2012) .
ES24 and ES47 were prepared in good yields by condensation of acyl hydrazides 1 and 2 with the appropriate conjugated aldehyde. Phenylacetic hydrazide 1 is commercially available and the synthesis of 2 (ESR35) has been reported previously (Cross et al., 2009a) . The double bond geometry in both compounds was confirmed by the magnitude of the corresponding vicinal 1 H-1 H coupling constant (15.9 Hz for ES24 and 14.8 Hz for ES47).
General experimental synthetic reagents and solvents were purchased from Sigma-Aldrich or Alfa Aesar and used as supplied. IR spectra were recorded on a Perkin Elmer 881 spectrometer, an AT1-Matson Genesis Series FTIR spectrometer or a Perkin Elmer Spectrum BX FTIR spectrometer.
1 H NMR spectra were recorded on a Bruker Avance II 500MHz spectrometer. Chemical shifts are referenced to the residual solvent peak. Mass spectra were recorded on a Micromass Platform II (electrospray) spectrometer. Melting points were recorded using a Sanyo Gallenkamp MPD350 heater and are uncorrected.
(E)-3-(5-Nitro-2-furyl)acrylaldehyde (128 mg, 0.77 mmol) was added, under nitrogen, to a solution of phenylacetic hydrazide (115 mg, 0.77 mmol) in anhydrous CH 3 OH (4 mL). The reaction mixture was stirred at room temperature overnight and then Et 2 O was added to allow complete precipitation to occur. (29) In Vitro Translocation Assay Nuclease-treated canine pancreatic microsomes were treated with 250 mM ESR35, ES1, ES2, ES24, ES47 (from 1 mM stock solutions in DMSO), or an equal volume of DMSO, and incubated on ice for 1 h before inclusion in translocation analyses. Cellfree translation (20 mL) was performed in nuclease-treated rabbit reticulocyte lysate (Promega) in the presence of EasyTag EXPRESS C. The short form of Ii was kindly provided by Dr. B. Dobberstein (ZMBH, Heidelberg University, Heidelberg, Germany). Following translation, puromycin was added to 0.1 mM and samples incubated for 5 min at 30 C to ensure ribosomal release. The membraneassociated fraction of the reaction was isolated by centrifugation (100,000 g for 10 min at 4 C in a TLA100 rotor (Beckmann) through an 80 mL high-salt cushion (0.75 M sucrose, 0.5 M KOAc, 5 mM Mg(OAc) 2 , 50 mM Hepes-KOH, pH 7.9) and the membrane pellet suspended in 30 mL SDS sample buffer (0.02% bromophenol blue, 62.5 mM, 4% (w/v) SDS, 10% (v/v) glycerol; pH 7.6; 1 M dithiothreitol). Samples were denatured at 70 C for 5 min prior to resolution by SDS-PAGE (10 mL sample, 16% polyacrylamide gels, 120 V, 120 min). Gels were incubated in fix mix (20% MeOH, 10% AcOH) for 5 min, dried (BioRad Gel Dryer) for 2 h at 65 C and exposed to a phosphore imaging plate for 24 h. Radiolabelled products were visualized using a Typhoon FLA-7000 (GE Healthcare). Quantitative analysis was performed with AIDA v5.0 (Raytest Isotopenmebger€ ate) whereby the signal intensity of Ii-2 Gly/Ii was used as a read-out for total translocation and expressed relative to the DMSO control to determine the mean relative ER processing from 3 independent experiments. Data is presented as mean ± SEM.
In Cellula Ubiquitination Assay Experiments performed whit HeLa cells cultured to $80% confluent. DMEM was aspirated from each well 16 h after cell plating and cells treated with 8 mM ES1, ES2, ES24, ESR35 and ES47 (from 10 mM stock solutions in DMSO), or an equal volume of DMSO, in 1 mL fresh DMEM for 8 h. Upon treatment completion, DMEM was aspirated, cells washed twice with PBS (Dulbecco's Phosphate Buffered Saline) and solubilized in 100 mL SDS sample buffer. Samples were denatured for 16 h at 37 C, resolved by SDS-PAGE (20 mL sample, 10% polyacrylamide gels, 120 V, 100 min) and proteins transferred to a PVDF membrane in transfer buffer (0.08 M Tris base, 0.60 M glycine, 20% MeOH) at 300 mA for 2.5 h at ambient temperature. The membrane was blocked in Casein blocking buffer (Sigma) diluted in TBS (Tris Buffered Saline; 0.2 M Tris base and 1.5 M NaCl; pH 7.4) for 1 h at ambient temperature prior to primary antibody (FK2 mouse (Enzo Life Sciences) and b-actin (Abcam)) incubation in Casein blocking buffer diluted 1:10 in TBST (TBS supplemented with 0.1% Tween-20) for 16 h at 4 C. After washing with TBST (4 x 10 min), the membrane was then incubated with a fluorescent secondary antibody for 1 h at ambient temperature. Following washing with TBST (4 x 10 min), samples were visualized using an Odyssey CLx Imaging System (LICOR Biosciences). Ubiquitin signals were normalized relative to the intensity of the b-actin loading control and normalized signals expressed relative to the DMSO solvent control. Data is shown as mean ± SEM from 6 independent experiments.
Gene Silencing
Silencing of SEC61A1 was performed in HeLa cells as previously described (Lang et al., 2011b ] cyt were imaged using D1ER and FURA-2, respectively. D1ER is a genetically encoded FRET-based Ca 2+ sensor that comprises two fluorescent proteins, CFP and citrine, and two sensing proteins, a calmodulin-binding peptide derived from skeletal muscle myosin light chain kinase and calmodulin (Palmer et al., 2004) . D1ER was stably expressed in HEK cells. FURA-2 is a ratiometric dye that localizes to the cytosol (see Lang et al., 2011b imaging experiments were carried out with the iMIC microscope, the polychromator V, and the Live Acquisition software (Till Photonics). To allow the recording of D1ER and FURA-2 signals in the same cells, the filter sets were automatically exchanged. Firstly, D1ER was excited by exposing HEK D1ER cells at 433 nm. The emitted florescence was then split at 469/23 nm and 536/27 nm to obtain the CFP and citrine components, respectively. The cell fluorescence was additionally passed through a dichrotome and projected on the chip of the microscope camera to obtain simultaneous CFP and citrine images. Secondly, FURA-2 was excited by alternated excitation at 340 and 380nm. The emitted fluorescence also passed through a dichrotome and captured at 510 nm to obtain FURA-2 images at 340 and 380 nm excitation. D1ER and FURA-2 image pairs containing 5-10 cells/frame were obtained every 10-12 s. D1ER ratios were calculated from CFP and citrine image pairs as F536/F469, where F536 and F469 represent the background-subtracted citrine and CFP fluorescence intensities, respectively. FURA-2 signals were measured in FURA-2 image pairs as F340/F380, where F340 and F380 correspond to the background-subtracted fluorescence intensity at 340 and 380 nm excitation wavelengths, respectively. Following corrections for bleed-through, F536/F469 and F340/F380 were used to calculate [Ca 2+ ] ER and [Ca 2+ ] cyt , respectively (see Sztretye et al., 2011; Lang et al., 2011b . Conversely, the R min of D1ER signals was the minimal F536/F469 ratio measured in the presence of 0.5 mM EGTA. The R max and R min of FURA-2 signals were determined in FURA-2 loaded HEK-D1ER cells as previously described (see Lang et al., 2011b was imaged with FURA-2 as previously described (see Lang et al., 2011b) . Stock solution of ES compounds were prepared by dissolving the compounds ES1, ES2, ES24, ESR35 and ES457 in DMSO to obtain concentrations of 10-100 mM. Stock were maintained frozen at -20 C. Similarly, 1 mM stocks of thapsigargin were prepared in DMSO. Just before experiments, stocks of TG and ES compounds were diluted to a 2X concentration in the bath solution, i.e., 2 times greater than the desired final concentration. Routinely, TG and ES compounds were applied to the cells during Ca 2+ imaging by adding 2X solutions to the bath at a ratio of 1:1 to avoid problems arising from slow mixing. The final DMSO concentration in bath was 0. Cell Viability Assay HEK, HeLa, INS-1 and NALM-6 cells were plated in culture dishes at densities between 0.25-0.50,10 6 cells/ml in the respective culture medium and treated with ES1, ES24 and ESR35 at concentrations between 1-20 mM for 24 h. Similarly, cells were treated with 1 mM thapsigargin for 24 h. The DMSO concentration was 0.1 % in TG-containing medium and below 0.02 % in medium with ES compounds. Following treatment, cells were incubated with PBS and Guava ViaCount reagent (1:10) for 5 min in the dark at room temperature. Cell viability was measured by flow cytometry with Guava easyCyte 8HT (Merck Millipore). Viability measurements were performed as duplicates in 3 independent experiments per treatment with 5000 cells/measurement. The cell viability of cells exposed to ES1, ES24 and ESr35 was normalised with respect to the viability of non-treated cells. For cells exposed to TG, cell viability was normalised to 0.1 % DMSO controls. Normalised viability data is presented as mean ± SD.
Homology Modelling and Docking Protocols
The protein sequence of human Sec61a isoform 1, which contains 476 amino acids, was retrieved from the UniProtKB database (UniProt: P61619). The crystal structure of canine Sec61a (PDB: 3JC2) was selected for homology modelling of human Sec61a. Both sequences share 99.8% sequence identity. The 3JC2 structure shows Sec61a in an open conformation but is lacking structural information for the helical plug region (residue 63 to 69). Since in the open conformation, the plug is believed to be outside of the translocation pathway, we assumed that it does not form relevant interaction with the substrates. Homology modelling was carried out using the MODELLER 9.17 package. The plug region was modelled and optimised as a loop structure. Subsequently, the homology model was subjected to energy minimization, using the NAMD package, to relax side chain atoms. The resulting model ( Figure 6A ) was validated by the ProSa-web server, along with two Sec61a structures (PDB: 3JC2 and PDB: 5A6U) and two other membrane protein structures: a GPCR (PCB: 3P0G) and an ABC transporter (PDB: 3G5U). The analysis from ProSa-web showed that the score of the homology model is within the range of scores typically found in experimentally determined structures of protein chains. The structural model of Sec61 a carrying the T86M mutation was generated by Swiss-Pdb Viewer and subsequent minimization with NAMD.
The protonation states of protein residues and partial charges of ligands were assigned by the prepare_receptor and prepare_ ligand modules of the AutoDock4 package. For each ligand, the docking calculations were performed in 2 consecutive steps: In the first docking step, we adopted a relatively large grid box covering the entire cavity of Sec61, to scan for energetically favourable conformations of the ligand inside the Sec61 pocket. The Lamarckian genetic algorithm was used for the optimization of the ligand conformations and orientations (cubic box of 45 Å , grid spacing, 2.5310 6 energy evaluations and 27 310 3 generations). In the second docking step, the size of the grid box was scaled down based on the population of the most stable binding positions of the ligand. In a finer run, more stringent parameters (cubic box of 34 Å , 100310 6 energy evaluations and 0.5310 6 generations) were used.
QUANTIFICATION AND STATISTICAL ANALYSIS
Quantification procedures used in vitro and in cellula experiments as well as in Ca 2+ imaging experiments are described in Method Details.
The statistical significance of in vitro and in cellula data with respect to DMSO controls was determined using Tukey's and Dunnett's multiple comparison tests, respectively. Statistical significance of the Ca 2+ imaging data was assessed with the twosample Kolmogorov-Smirnov test. Statistical significance is given as n.s., non-significant; *, P < 0.05; **, P < 0.01 and ***, P < 0.001.
DATA AND SOFTWARE AVAILABILITY
In vitro data was analysed with AIDA. Matlab was used in the analysis of Ca 2+ imaging data. Homology modelling and docking analysis were performed with Modeller 9.17, NAMD, Pro-Sa-web and AutoDock4.
